XENE (Xenon Pharmaceuticals) Buyback Yield %: -14.22 (As of Jul. 04, 2026)


XENE Xenon Pharmaceuticals Inc XENE
25 GF Score
Price $60.92
! 5 Warning Signs
View Full Analysis

What is Xenon Pharmaceuticals Buyback Yield %?

Xenon Pharmaceuticals XENE +1.09% 25 Buyback Yield % is -14.22 as of Jul. 04, 2026. GuruFocus rates XENE with a GF Score™ of 25/100. The stock has 5 warning signs investors should review. Among 744 Biotechnology companies, Xenon Pharmaceuticals ranks worse than 59.54% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Xenon Pharmaceuticals's current buyback yield was -14.22%.

Xenon Pharmaceuticals Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Xenon Pharmaceuticals's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xenon Pharmaceuticals Buyback Yield % Chart

Xenon Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -27.73 -11.26 -10.18 -0.40 -3.13

Xenon Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -3.13 -14.91

XENE vs DFTX, LEGN, TVTX: Buyback Yield % Comparison

For the Biotechnology subindustry, Xenon Pharmaceuticals's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xenon Pharmaceuticals Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xenon Pharmaceuticals's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Xenon Pharmaceuticals's Buyback Yield % falls into.


XENE
25GF Score
Xenon Pharmaceuticals Inc XENE
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Xenon Pharmaceuticals Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Xenon Pharmaceuticals's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 112.151) / 3586.09302
=-3.13%

Xenon Pharmaceuticals's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 837.526) / 5618.6856
=-14.91%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -14.22 mean?
Xenon Pharmaceuticals (XENE) has a Buyback Yield % of -14.22 as of Jul. 04, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Xenon Pharmaceuticals and its competitors. According to the industry distribution chart, Xenon Pharmaceuticals ranks #443 out of 744 companies in the Biotechnology industry, placing it in the top 59.5%.
Is Xenon Pharmaceuticals' Buyback Yield % too high?
Xenon Pharmaceuticals' current Buyback Yield % is -14.22. Based on the distribution chart, Xenon Pharmaceuticals ranks #443 out of 744 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Xenon Pharmaceuticals has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Xenon Pharmaceuticals' Buyback Yield % compare to DFTX and LEGN?
According to the Biotechnology industry distribution chart, Xenon Pharmaceuticals ranks #443 out of 744 companies for Buyback Yield %. This places Xenon Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Xenon Pharmaceuticals and its competitors. Xenon Pharmaceuticals's current Buyback Yield % is -14.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xenon Pharmaceuticals stock overvalued right now?
Xenon Pharmaceuticals (XENE) has a current Buyback Yield % of -14.22. The current Buyback Yield % is -14.22. Xenon Pharmaceuticals' overall GF Score™ is 25/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Xenon Pharmaceuticals (XENE), the current Buyback Yield % is -14.22 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Xenon Pharmaceuticals Business Description

Other Exchanges XP0:Germany
Address 200-3650 Gilmore Way, Burnaby, BC, CAN, V5G 4W8
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
25GF Score

Get the complete analysis for XENE

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$60.92
Price